dc.description.abstract | Background: The pharmaceutical industry is a business entity that has a permit in
accordance with the provisions of laws and regulations to carry out the activities
of making drugs or drug ingredients. Therefore, the demands on the
pharmaceutical industry are increasing because the role of the pharmaceutical
industry is very important in terms of producing safe, efficacious and quality
drugs. Quality, safe and effective drugs are produced through the process of
implementing CPOB (Good Manufacturing Practices for Drugs).
Objective: To understand the duties and roles of pharmacists regarding Good
Manufacturing Practices in industry.
Method: Research or PKPA activities were carried out by participating in work
practice activities in the pharmaceutical industry of PT. Kimia Farma Plant
Jakarta and comparing work practices carried out in the field with good
manufacturing practice guidelines (CPOB).
Results: PKPA activities at PT. Kimia Farma Plant Jakarta were carried out from
September 9 to November 13, 2024. In general, there are two PKPA activities at
PT. Kimia Farma Plant Jakarta, namely the provision of induction by departments
related to pharmaceutical work at PT. Kimia Farma Plant Jakarta such as the
PPIC, QC, QA, storage, packaging, engineering and maintenance departments,
central weighing, HR and accounting and waste processing, and production. The
implementation of CPOB at PT. Kimia Farma Plant Jakarta can be seen in various
aspects of activities such as aspects of the quality system, personnel, and so on.
Conclusion: The level of PT. Kimia Farma Tbk. Plant Jakarta has implemented
aspects of CPOB well. This is proven by obtaining a CPOB certificate.
Prospective pharmacists get a real picture of the implementation of CPOB at PT.
Kimia Farma Tbk. Plant Jakarta in the form of implementing aspects of quality
management, personnel, buildings and facilities, equipment, sanitation and
hygiene, production, quality control, self-inspection and quality audit, handling
complaints about products, product recalls and returned products, documentation,
and qualification and validation. | en_US |